CRVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Corvus Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$9.65+0.13 (+1.37%)
Close on Oct 19, 2026
- Market cap
- $891.35M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Corvus Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 21, 2026 | Jul 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2026 | Mar 13, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2026 | Jan 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 20, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2025 | Oct 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 9, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2024 | Dec 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2024 | Oct 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 7, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 6, 2024 | May 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 1, 2024 | SEC EDGAR |